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Abstract
Background. Self-administered questionnaires are widely used in primary care and other clin-
ical settings to assess the severity of depressive symptoms and monitor treatment outcomes.
Qualitative studies have found that changes in questionnaire scores might not fully capture
patients’ experience of changes in their mood but there are no quantitative studies of this
issue. We examined the extent to which changes in scores from depression questionnaires dis-
agreed with primary care patients’ perceptions of changes in their mood and investigated fac-
tors influencing this relationship.
Methods. Prospective cohort study assessing patients on four occasions, 2 weeks apart.
Patients (N = 554) were recruited from primary care surgeries in three UK sites (Bristol,
Liverpool and York) and had reported depressive symptoms or low mood in the past year
[68% female, mean age 48.3 (S.D. 12.6)]. Main outcome measures were changes in scores
on patient health questionnaire (PHQ-9) and beck depression inventory (BDI-II) and the
patients’ own ratings of change.
Results. There was marked disagreement between clinically important changes in question-
naire scores and patient-rated change, with disagreement of 51% (95% CI 46–55%) on
PHQ-9 and 55% (95% CI 51–60%) on BDI-II. Patients with more severe anxiety were less
likely, and those with better mental and physical health-related quality of life were more likely,
to report feeling better, having controlled for depression scores.
Conclusions. Our results illustrate the limitations of self-reported depression scales to assess
clinical change. Clinicians should be cautious in interpreting changes in questionnaire scores
without further clinical assessment.
Introduction
Self-administered screening questionnaires that assess the severity of depressive symptoms
have been recommended in UK primary care and in North America and some parts of
Europe (Kendrick et al., 2009; Thombs & Ziegelstein, 2014). These recommendations were
made in response to concerns that depression is under-diagnosed and under-treated in pri-
mary care, with the aim of improving detection and monitoring treatment response. In
2006 the quality outcomes framework (QOF) in the UK encouraged the use of three question-
naires through monetary compensation to practices: the patient health questionnaire (PHQ-9),
the beck depression inventory (BDI-II) and the hospital anxiety and depression scale (HADS).
These questionnaires are no longer incentivized but remain widely used in UK primary care
and continue to influence treatment decisions (Kendrick et al., 2009). The PHQ-9 along with
other questionnaires is also used as a routine outcome measure in improving access to psycho-
logical therapies (IAPT) services in the UK (Clark et al., 2018).
Self-administered depression questionnaires have been compared to diagnostic assessments
and their sensitivity and specificity are fairly good, at around 80% (Beck, Guth, Steer, & Ball,
1997; Moriarty, Gilbody, McMillan, & Manea, 2015). However, their use in clinical settings has
been criticized (Dowrick et al., 2009; Toop, 2011). One concern is that changes in scores might
not fully capture the patient’s experience of improvement or deterioration in their mood. Such
disagreement has important implications for treatment decisions and patient-centred care
(Malpass et al., 2016; Robinson et al., 2017).
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Improvement is commonly rated by clinicians within research
settings with the single-item measure, the clinical global
impression-improvement scale (CGI-I). Research comparing the
CGI-I with routine patient self-report measures in psychiatric set-
tings has found good levels of agreement, although differences
were also observed (Berk et al., 2008; Zaider, Heimberg, Fresco,
Schneier, & Liebowitz, 2003). Clinicians also routinely ask
patients whether their condition has improved, deteriorated or
stayed the same (Fischer et al., 1999; Kamper, Maher, &
Mackay, 2009). Patient-rated change is measured in research set-
tings with a single-item question, which asks patients retrospect-
ively about how their whole condition has changed compared to a
previous occasion, rather than asking about individual symptoms
(Fischer et al., 1999; Kamper et al., 2009).
We have conducted qualitative studies of people whose self-
rated changes in mood differed from their responses to self-
administered depression scales (Malpass et al., 2016; Robinson
et al., 2017). Patients explained the disagreement as resulting
from the presence of co-morbid conditions, negative and positive
life events, changes in social support and changes in quality of life
(Robinson et al., 2017). This supports other qualitative findings
that patients often state that scales such as the PHQ-9 do not
fully capture their experience of illness (Malpass et al., 2016).
We are not aware of any similar qualitative or quantitative inves-
tigations of this question.
In this study, we used a cohort of patients recruited from pri-
mary care to investigate the extent to which responses to the
PHQ-9 and BDI-II disagreed with patients’ perceptions of
changes in their mood, assessed using a patient-rated change
scale. We also investigated factors that might influence patient
reports of self-improvement having controlled their responses
on the PHQ-9 and BDI-II.
Methods
Participants
Participants were recruited from general practice (GP) surgeries in
three UK sites: Bristol, Liverpool and York. Computerized records
were used to identify patients aged 18–70 who had reported low
mood, depressive episodes, depressed mood, depressive symptoms
or a major depressive episode in the past year, irrespective of any
treatment. We excluded patients who: were diagnosed with bipo-
lar disorder, psychosis or eating disorder; had alcohol or sub-
stance use problems; were unable to complete study
questionnaires; or were 30 weeks or more pregnant. A total of
7721 patients were sent an information letter and 1470 (19%)
replied. Of these, 821 were willing to be contacted, 23 (3%) of
whom were ineligible. The remaining 798 were contacted to
arrange an interview. Of these, 563 consented (38%) and 559
(38%) were interviewed (four could not be contacted). Data
were collected at four time-points, 2 weeks apart (baseline and
follow-up 1, 2 and 3). Patients and public representatives were
involved in management and steering groups for the PANDA
programme grant and gave input into the design, conduct and
interpretation of the study.
Ethical approval
All participants provided written informed consent and ethical
approval was obtained from NRES Committee South West –
Central Bristol. The authors assert that all procedures
contributing to this work comply with the ethical standards of
the relevant national and institutional committees on human
experimentation and with the Helsinki Declaration of 1975 as
revised in 2008.
Measures
Depressive symptoms: The PHQ-9 and BDI-II were completed at
each time-point. The PHQ-9 is a 9-item self-administered meas-
ure of depressive symptoms in the past 2 weeks and scores range
from 0 to 27 (Kroenke, Spitzer, & Williams, 2001). Internal con-
sistency was high at each time-point (Cronbach’s α 0.89–0.92).
The BDI-II is a 21-item self-administered measure of the severity
of depressive symptoms in the past 2 weeks (Beck et al., 1997) and
scores range from 0 to 63. Internal consistency was high at each
time-point (Cronbach’s α 0.93–0.95). Higher scores indicate
more severe depressive symptoms.
Patient-rated change: We used a single-item question based on
‘Global Rating Scales’ that are routinely used in musculoskeletal
and chronic pain research and have high reliability and validity
(Fischer et al., 1999; Kamper et al., 2009). Participants were
asked ‘compared to when we last saw you 2 weeks ago how
have your moods and feelings changed?’ Response options were:
‘I feel a lot better’ (1), ‘I feel slightly better’ (2), ‘I feel about the
same’ (3), ‘I feel slightly worse’ (4), ‘I feel a lot worse’ (5). We
used ‘moods and feelings’ instead of ‘depression’ because many
people might not consider themselves ‘depressed’ and this word-
ing should encourage a more general response. Our qualitative
studies found evidence that patients viewed this question as
more open-ended and explorative, stating that it allowed them
to ‘sum up’ their mental health and express themselves outside
of the parameters of the questionnaires (Robinson et al., 2017).
The patient-rated change scale was completed twice at each time-
point, at the beginning and end of the questionnaire. Test-retest
reliability was good with kappa (quadratic weights) of 0.89. The
scale, or similar, has been used in prior randomized controlled
trials (Button et al., 2015; Malpass et al., 2016; Robinson et al.,
2017).
Anxiety: The generalized anxiety disorder assessment
(GAD-7) (Spitzer, Kroenke, Williams, & Löwe, 2006) was com-
pleted at each time-point and is a 7-item self-administered meas-
ure of the severity of anxiety symptoms in the past 2 weeks, scores
ranging from 0 to 21. Higher scores indicate more severe
symptoms.
Physical and Mental Health-Related Quality of Life: The
12-item short-form health survey (SF-12) (Ware, Kosinski, &
Keller, 1996) was administered at each time-point. Separate phys-
ical and mental health-related quality of life scores were derived
(Ware et al., 1996). Scores range from 0 to 100, higher scores indi-
cating better quality of life.
Negative Life Events: At baseline (only), participants were
asked, using a self-administered computerized questionnaire,
whether they had experienced the following in the previous 6
months: (i) bereavement, (ii) separation or divorce, (iii) a serious
illness or injury, (iv) victimization (mugging, burglary, serious
assault), (v) being in trouble with the law, (vi) debt, (vii) a serious
dispute with a family member or friend, or (viii) being made com-
pulsorily redundant from work. Due to the low frequency, a bin-
ary variable was created (none or 1 or more).
Social Support: At baseline (only), participants completed
eight questions as part of the self-administered computerized
questionnaire relating to: (i) feeling loved, (ii) having others that
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can be relied on, (iii) feeling accepted, (iv) feeling supported, (v)
having others to talk to, (vi) having others that make them happy,
(vii) having others that care what happens to them and (viii) hav-
ing others that make them feel an important part of their lives.
Each question used a three-point scale (1) not true, (2) partly
true and (3) certainly true. Scores were summed and ranged
from 1 to 24, higher scores indicating more social support.
Potential confounders: We adjusted for variables previously
shown to be associated with depressive symptoms, and site.
Demographic variables (age, sex, ethnicity, employment status,
financial status and education level) were measured at baseline.
Due to small numbers, ethnic minority status was a binary vari-
able. Employment status was categorized as employed,
unemployed not by choice and unemployed by choice.
Financial status was three categories: low (‘Finding it very difficult
to make ends meet’ and ‘Finding it difficult to make ends meet’),
medium (‘Just about getting by’) and high (‘Living comfortably’
and ‘Doing alright’). Education level was seven categories, from
no qualifications to a higher degree.
Statistical analyses
Identifying disagreement between questionnaire scores and
patient-rated change
To calculate change scores, mean PHQ-9 and BDI-II scores at
each follow-up time-point were subtracted from mean scores at
the previous time-point (to correspond to the patient-rated
change scale which asks about change over the last 2 weeks).
Possible change scores ranged from −27 to +27 for PHQ-9 and
−63 to +63 for BDI-II. Greater negative scores indicated improve-
ment and greater positive scores indicated deterioration.
We used the minimal clinically important difference (MCID),
the smallest change in symptoms meaningful to patients, to assess
the extent of disagreement (Button et al., 2015). The MCID has
been estimated in the PANDA cohort to be around a 20% reduc-
tion in PHQ-9 or BDI-II scores (manuscript in preparation). We
used the MCID of a 20% reduction or increase in questionnaire
scores to create the following categories: clinically important
decreases (a decline in scores of 20% or more), no clinically
important change (a decline or increase in scores smaller than
20%) and clinically important increases (an increase in scores
greater than or equal to 20%) (Button et al., 2015). For each
response option on the patient-rated change scale, we report the
proportion of patients in each of the above MCID categories.
As test-retest reliability for the patient-rated change scale was
good (κ = 0.89) we used the rating from the beginning of the
assessment. Disagreement did not vary substantially when the rat-
ing completed at the end of the assessment were used (online
Supplementary Table S3).
We defined disagreement as (i) a clinically important change
in PHQ-9/BDI-II scores and a rating of change response that
indicated either no change or a change in the opposite direction
(ii) no clinically important change in PHQ-9/ BDI-II scores
and a rating of change response that indicated a change in either
direction. The proportion of patients showing some form of dis-
agreement overall was calculated overall by dividing the total
number of people showing disagreement with the total number
of people. Proportion disagreement was also calculated within
each patient-rated response category. Quadratic weighted and
unweighted kappa values were used to test agreement between
the patient rating of change responses and MCID categories. In
a prior manuscript, we had identified a MCID of 15% for the
BDI-II (Button et al., 2015) so we conducted sensitivity analyses
with this estimate.
Reliability of disagreement
We further examined the extent of disagreement by tabulating the
proportion of participants scoring within each category of the
patient-rated change scale with the equivalent proportion scoring
a corresponding change on the PHQ-9/BDI-II (online
Supplementary Analyses). For example, if 10% of patients
reported feeling much better, this was tabulated against the top
10% of change scores on the PHQ9/BDI-II and so on for the per-
centage who reported feeling slightly better, the same, slightly
worse or worse. Quadratic weighted and unweighted kappa values
were used to test agreement between these proportions.
Variables that influence disagreement
We used a binary outcome (feeling better v. same or worse) to
reflect that neither feeling the same nor worse is a good clinical
outcome. As the patient-rated change scale asks about the last 2
weeks, we could construct logistic models with the 2, 4 or 6
week follow-up as the outcome. We adjusted for binary clinically
important change (20% change in scores or not) over the previous
2-weeks. This binary variable reduced collinearity between
depression scores and other exposures (e.g. anxiety) and was con-
sistent with our approach to clinically important change and
disagreement.
For exposures measured at multiple time-points (anxiety,
mental and physical-health-related quality of life,) we did a prin-
cipal components analyses of the exposure at the current and
preceding time-points. Principal components analysis (PCA)
can be used to transform two correlated variables into orthog-
onal (uncorrelated) factors or ‘principal components.’ The first
component is a function of the average score on each variable.
The second component is uncorrelated with the first and is a
function of the difference between two scores (Jolliffe &
Cadima, 2016). Models were adjusted for confounders known
to be associated with depressive symptoms (age, sex, ethnicity,
education level, current use of antidepressants and marital,
financial and employment status) and site. All analyses were
conducted using STATA 14.
Role of the funding source
The funding source had no role in study design, data collection,
data analysis, interpretation or writing of the report. The corre-
sponding author had full access to all data used in the study,
and final responsibility for the decision to submit for publication.
Results
Due to extensive missing data at baseline five patients were
excluded, leaving 554 for analyses. At follow-ups 1, 2, and 3:
476 (86%); 443 (80%), and 430 (78%) provided data, respectively.
Baseline sample characteristics are presented in Table 1. Patients
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Identifying disagreement between questionnaire scores and
patient-rated change
Disagreement between questionnaire scores and the patient-rated
change scale was similar across time-points, so data from baseline
to follow-up 1 are presented for brevity. Results for further follow-
ups are available in online Supplementary Table S1).
Depression change scores according to patient-rated change
Change in depression questionnaire scores was related to patients’
responses on the rating scale. Patients who reported ‘feeling a lot
better’ had the largest mean decrease in scores and patients who
reported ‘feeling a lot worse’ the largest increase (Table 2, first row
in PHQ9 and BDI-II sections).
Clinically important change in depression scores according to
patient-rated change
When clinically important differences in depression scores were
compared to patient ratings, there was evidence of disagreement.
The proportion of patients showing each type of clinically import-
ant change in questionnaire scores (increase, no change,
decrease), in comparison to their responses is presented in
Table 2.
Disagreement was most common in patients who reported
feeling worse on the patient-rated change scale. PHQ-9 scores
showed no change or an improvement for 76% (95% CI 66–
83%) of those who reported ‘feeling slightly worse’, and 81%
(95% CI 54–94%) of those who reported ‘feeling a lot worse’
(Table 2, last row in PHQ-9 section). These results were very simi-
lar for the BDI-II (Table 2, last row in BDI-II section).
Disagreement was also common in patients who reported feeling
better. PHQ-9 scores remained the same or deteriorated in 65%
(95% CI 55–74%) of those who reported ‘feeling slightly better’,
and 53% (95% CI 37–67%) of those who reported ‘feeling a lot
better’ (Table 2, last row in PHQ-9 section). Disagreement was
lower for patients who reported feeling better on the BDI-II:
43% (95% CI 34–53%) for those reporting feeling slightly better
and 28% (95% CI 16–43%) for those reporting feeling much bet-
ter (Table 2, last row in BDI-II section). Overall, the proportion of
people showing some form of disagreement was 51% (95% CI 46–
55%) on the PHQ-9 and 55% (95% CI 51–60%) on the BDI-II.
This was similar at follow-up time points for the PHQ-9
[follow-up 1–2: 49% (95% CI 45–54%), follow-up 2–3: 51%
(95% CI 46–56%)] and BDI-II [follow-up 1–2: 50%, 95% CI
46–55%, follow-up 2–3: 52% (95% CI 47–57%)]. When using a
more stringent minimal clinically important difference of 15%,
results were comparable (online Supplementary Table S2).
Quadratic weighted Kappa scores indicated agreement between
patient ratings and the categories generated from the change
scores ranging 81.2–83.6% for the PHQ-9 and 78.6–83.1% the
BDI-II. Unweighted Kappa scores indicated low levels of agree-
ment (3.9–7.6%) for PHQ-9 and BDI-II.
Reliability of disagreement
Results were similar when the proportion of patients scoring
within each category of the patient-rated change scale were com-
pared with the relative proportion of patients scoring within these
ranges on the PHQ-9 and BDI-II (online Supplementary
Table S4). High agreement was observed between the
patient-rated change scale and PHQ-9/BDI-II, with weighted
kappa values indicating agreement ranging 91.4–93.1% across
time-points. Unweighted kappa values indicated poorer agree-
ment (37.9–42.4%). We found no evidence that disagreement dif-
fered according to gender (results available on request).
Variables that influence disagreement
Results for the PHQ-9 are shown in Table 3 and for the BDI-II,
Table 4. We found evidence that an increase in anxiety symptoms
was associated with a decreased odds of reporting feeling better
after controlling for changes in depressive symptoms. This was
consistent across time-points, for PHQ-9 and BDI-II. For example
at follow-up 1, a four-point increase in anxiety scores was asso-
ciated with a 0.67 (95% CI 0.55–0.82) decrease in the odds of feel-
ing better, having controlled for change in PHQ-9 scores.
We also found consistent evidence that improved mental and
physical health-related quality of life was associated with
increased odds of reporting feeling better after controlling for
changes in depressive symptoms. For example at follow-up 1,
an eight-point increase in mental health-related quality of life
was associated with a 1.43 (95% CI 1.11–1.61) increase in the
odds of feeling better. For physical health-related quality life
this odds ratio was 1.28 (1.08–1.54). There was no evidence of
an influence of negative life events or social support on the like-
lihood of reporting improvement (Tables 3 and 4). We found no
evidence that any of these associations differed according to gen-
der (available on request).
Discussion
Summary of findings
We found evidence that changes in scores on self-administered
depression questionnaires often differ from patients’ own views
of changes in their mood. Over 50% of people evidenced some
form of disagreement between their questionnaire scores and self-
rated mood. Even though on average, there is fairly good agree-
ment between change in depressive symptoms and self-rated
changes in mood, our results suggest that applying these question-
naires to individual patients will be prone to error.
Patients with more severe anxiety symptoms were less likely,
and those with better mental and physical health-related quality
of life more likely, to report feeling better having controlled for
Table 1. Sample characteristics at baseline
Demographic variable Overall sample (n = 554)
Age, mean (S.D.) 48.30 (12.56)
Female, N (%) 377 (68)
White, N (%) 530 (96)
Married or partnership, N (%) 278 (50)
Employed, N (%) 296 (53)
Higher education, N (%) 161 (29)
ICD-10 depression diagnosis, N (%) 238 (45)
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their depression questionnaire scores. Our results support the idea
that self-administered scales only capture a subset of the subject-
ive experience that contributes to patient-rated change and sug-
gests that relying solely upon responses to self-administered
scales could be misleading in a large proportion of situations.
Strengths and limitations
We set broad and inclusive entry criteria to reflect the patients
consulting for depression in primary care. The MCID allowed
us to infer that differences were clinically important, though we
acknowledge that the MCID is itself an average determined by ref-
erence to patients self-rated change. Our results indicate that such
average MCIDs are difficult to apply in individual cases, even if
they are valuable overall in planning and interpreting studies.
The depression questionnaires and patient-rated change scale
will be subject to measurement error, which could be a potential
source of disagreement. Multi-item scales with specific prompts
might be more reliable (Kamper et al., 2009), but the reliability
of the patient-rated change scale was good. There could be
other reasons for disagreement. The patient-rated change scale
asks retrospectively about change and recall might be poor
(Herrmann, 1995). However, the recall period (2 weeks) was the
same for the depression questionnaires and patient-rated change
scale. ‘Response shift’ is the concept that answers will differ across
time not because the condition has changed but because the opin-
ion on what the condition means has changed (Schwartz &
Sprangers, 1999). This might also lead to disagreement if it
occurred. Finally, it is unclear which aspects of the patients’ con-
dition have informed the response to the patient-rated change
scale. However, these points are largely concerned with explaining
the differences between the two contrasting approaches to assess-
ment rather than casting doubt on our conclusions.
There was a low response rate for the study and this might have
affected the representativeness of our target population which was
patients seeking help in primary care. However, it seems unlikely
that our method of recruitment and the low response rate would
inflate the level of disagreement although we cannot rule out that
possibility. Our sample was from the UK and predominantly
white and this may limit generalizability. Finally, there was attrition
though retention was good with 78% at the final follow-up.
These quantitative findings are partly consistent with our pre-
vious qualitative findings (Malpass et al., 2016; Robinson et al.,
2017). Of course, the PHQ-9 and BDI-II only measure depression
symptoms so it is unsurprising that anxiety should affect
patient-rated change in mood and feelings independently. Given
the co-occurrence of depression and anxiety it is important to rec-
ognize that, from the patients’ perspective, changes in anxiety will
also be important.
The PHQ-9 and BDI-II are recommended for assessment of
depressive illness and treatment response in UK primary care
and other clinical settings. Our results emphasize the importance
of using these measures alongside clinical assessments that take in
the perspective of the patient. Sole reliance upon information
from self-administered questionnaires can potentially be mislead-
ing and ignores areas that patients’ regard as important. Our evi-
dence supports the widespread scepticism among physicians
about using self-administered questionnaires in clinical practice
(Dowrick et al., 2009). We provide quantitative evidence that
the results of these questionnaires need to be interpreted along
with other clinical assessments and should not be relied upon
alone. Our findings support the concept of ‘personal recovery’,
developed in mental health services but also relevant in primary
care (Bejerholm & Roe, 2018; Burgess, Pirkis, Coombs, &
Rosen, 2011). Personal recovery emphasizes the importance of a
holistic focus on patients’ broad experiences rather than a
restricted focus on ‘clinical recovery’ or symptom change. This
makes the patients’ voice of central importance and there are
efforts under-way to devise better measurements of patient-
reported recovery.
Table 2. Change in depression severity according to the patient-rated change scale, compared to clinically important changes in PHQ-9 and BDI-II scores
Patient-rated change scale










Mean (S.D.) change −3.4 (4.1) −2.7 (3.9) −0.26 (3.6) 1.3 (4.3) 1.6 (5.4)
CID decrease, n (%)a 19 (47%) 34 (35%) 29 (14%) 9 (9%) 2 (13%)
No CID change, n (%)a 20 (50%) 56 (58%) 149 (70%) 65 (66%) 11 (69%)
CID increase, n (%)a 1 (3%) 7 (7%) 36 (16%) 24 (25%) 3 (18%)
Disagreement, n (%)b 21 (53%) 63 (65%) 65 (30%) 74 (75%) 13 (82%)
BDI-II
Mean (S.D.) change −8.0 (8.9) −5.6 (6.5) −1.2 (5.8) 0.0 (5.7) 3.2 (7.1)
CID decrease, n (%)a 29 (72%) 55 (57%) 74 (34%) 21 (22%) 3 (18%)
No CID change, n (%)a 9 (23%) 33 (34%) 92 (42%) 48 (49%) 9 (53%)
CID increase, n (%)a 2 (5%) 9 (9%) 51 (24%) 28 (29%) 5 (29%)
Disagreement, n (%)b 11 (28%) 42 (43%) 125 (58%) 69 (71%) 12 (71%)
CID, clinically important difference based on the minimal CID (MCID).
Disagreement (differing indications of change in depressive symptoms) is shaded in grey (n = 465 PHQ-9, n = 468 BDI-II).
aPercentages represent the proportions of patients showing differing CID changes (decrease, no change, increase) within each category of the global rating of change scale.
bPercentages represent the proportions of patients showing disagreement within each category of the global rating of change scale.
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Some patients view self-administered questionnaires positively
and request them to monitor their recovery (Moore et al., 2012).
Questionnaires can, therefore, play a useful role in outcome
assessment, in conjunction with the clinical assessment that
takes account of more holistic changes in mood. They are also
useful as a guide for service level outcome assessment (Clark
et al., 2018). In clinical trials, self-administered questionnaires
are widely used for comparing groups and such randomized
comparisons should be unbiased. Our findings suggest, though,
that additional questions should also be used to assess the out-
come of treatments in research studies.
Future research could examine the generalizability of our find-
ings to international settings and mental health services, and the
relationship between patient-rated change and other mental
health measures including the outcomes used in the NHS improv-
ing access to psychological therapy services (Clark et al., 2018).
Table 3. Association between exposure variables and the odds of reporting feeling better (v. the same or worse), adjusted for change on the PHQ-9
Exposure variable
Odds ratio for reporting feeling better (v. the same or worse), 95% confidence interval and p value (n = 375)
Baseline to follow-up 1 Follow-up 1–2 Follow-up 3–4
Anxiety symptomsa Unadjusted
Feeling same or worse ref ref ref
Feeling better 0.67 (0.55–0.82) <0.0001 0.65 (0.53–0.79) <0.0001 0.71 (0.59–0.86) <0.0001
Adjustedb
Feeling same or worse ref ref ref
Feeling better 0.66 (0.54–0.82) 0.016 0.61 (0.49–0.76) <0.0001 0.72 (0.60–0.97) 0.001
Mental health-related quality of lifea Undjusted
Feeling same or worse ref ref ref
Feeling better 1.34 (1.11–1.61) 0.002 1.33 (1.11–1.59) 0.002 1.38 (1.15–1.64) 0.000
Adjustedb
Feeling same or worse ref ref ref
Feeling better 1.32 (1.08–1.61) 0.006 1.38 (1.14–1.66) 0.001 1.40 (1.17–1.68) <0.000
Physical health-related quality of lifea Unadjusted
Feeling same or worse ref ref ref
Feeling better 1.28 (1.07–1.54) 0.007 1.25 (1.06–1.48) 0.009 1.20 (1.01–1.42) 0.039
Adjustedb
Feeling same or worse ref ref ref
Feeling better 1.32 (1.08–1.60) 0.006 1.32 (1.10–1.58) 0.002 1.19 (.99–1.43) 0.057
Negative life eventsc Unadjusted
Feeling same or worse ref ref ref
Feeling better 0.98 (0.61–1.59) 0.94 1.13 (0.72–1.79) 0.59 1.17 (0.74–1.85) 0.50
Adjustedb
Feeling same or worse ref ref ref
Feeling better 0.99 (0.60–1.65) 0.98 1.11 (0.69–1.78) 0.76 1.15 (0.72–1.85) 0.56
Social supportd Unadjusted odds Ratio (95% CI) p value
Feeling same or worse ref ref ref
Feeling better 1.07 (1.00–1.14) 0.067 1.01 (0.95–1.07) 0.71 1.02 (0.96–1.08) 0.56
Adjustedb
Feeling same or worse ref ref ref
Feeling better 1.07 (1.00–1.15) 0.045 1.02 (0.96–1.08) 0.59 1.01 (0.95–1.08) 0.76
aFor exposures measured at every time-point (anxiety and quality of life), odds ratios represent the odds of reporting feeling better for each four-point increase in anxiety symptoms over time
(on a factor score obtained using principal components analysis), adjusted for a binary indicator of meaningful change on the PHQ9.
bAdjusted for age, sex, ethnicity, site, education level, current use of antidepressants and marital, financial and employment status.
cNegative life events were measured at baseline only. The odds ratio represents the odds of feeling better in those who reported one life event or more compared to those who reported no
life events, adjusted for a binary indicator of meaningful change on the PHQ9.
dSocial support was measured at baseline only. The odds ratio represents the odds of reporting feeling better for each standard deviation increase in social support, adjusted for a binary
indicator of meaningful change on the PHQ9.
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Future clinical trials could also use the patient-rated change in
mood question as an outcome that might help to address the lim-
itations of existing measures.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291719003878.
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Adjustedb
Feeling same or worse ref ref ref
Feeling better 0.65 (0.53–0.81) <0.0001 0.61 (0.49–0.76) <0.0001 0.71 (0.59–0.86) <0.0001
Mental health-related quality of lifea Undjusted
Feeling same or worse ref ref ref
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Feeling better 1.25 (1.04–1.49) 0.016 1.24 (1.05–1.46) 0.013 1.22 (1.03–1.45) 0.021
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Adjustedc
Feeling same or worse ref ref ref
Feeling better 1.07 (1.00–1.15) 0.044 1.02 (0.96–1.08) 0.59 1.01 (0.95–1.08) 0.70
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(on a factor score obtained using principal components analysis), adjusted for a binary indicator of meaningful change on the PHQ9.
bSocial support was measured at baseline only. The odds ratio represents the odds of reporting feeling better for each standard deviation increase in social support, adjusted for a binary
indicator of meaningful change on the PHQ9.
cAdjusted for age, sex, ethnicity, site, education level, current use of antidepressants and marital, financial and employment status.
dNegative life events were measured at baseline only. The odds ratio represents the odds of feeling better in those who reported one life event or more compared to those who reported no
life events, adjusted for a binary indicator of meaningful change on the PHQ9.
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